According to the latest report by IMARC Group, titled “Blood Purification Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global blood purification equipment market size reached US$ 18.1 Billion in 2021.  Blood purification equipment refers to the devices that are used in medicine for extracting and purifying blood for the treatment of disorders refractory to conventional therapies. They function by drawing blood from an artery and sending it through a tube to the equipment for filtration procedures through bioseparation techniques to improve the cell's immune response. With the help of their thin fibers, viruses, pathogens, cytokines and other inflammatory mediators are captured and removed from the blood, and the purified blood is pumped back. A wide range of blood purification devices are used in plasmapheresis for toxicants, hemodialysis for kidney failures, and immunoadsorption for autoimmune diseases, as well as plasmapheresis for toxicants. Among the most commonly used equipment are hemodialysis, blood filtration, continuous renal replacement therapy (CRRT), hemoperfusion, and plasma exchange machines.

Global Blood Purification Equipment Market Trends:

The global market is majorly driven by the rising incidences of various metabolic and immune disorders, such as kidney failures, diabetes and hypertension. This can be attributed to the expanding geriatric population that is susceptible to developing these ailments. In addition to this, a considerable rise in the adoption of at-home care settings for the elderly population resulting in a higher uptake of portable and economical blood purification equipment is providing an impetus to the market. Also, the escalating demand blood purification devices across healthcare facilities due to continual technological developments in the medical infrastructure, particularly in the developing economies, is fueling the market. Moreover, extensive research and development (R&D) activities in the biotechnology, hematology and pathophysiology applications are creating a positive market outlook. In line with this, numerous product innovations, such as equipment with biofeedback loops and personalized dialysis prescription capabilities, are creating lucrative growth opportunities in the market. Some of the other factors, such as the rising popularity of minimally invasive (MI) surgery procedures, the growing awareness regarding early diagnosis and care, the widespread adoption of digitization across the medical sector, rapid urbanization and inflating disposable income levels of the consumers. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 27.3 Billion by 2027, exhibiting a CAGR of 6.62% during 2022-2027.

Market Summary:

• Based on the product type, the market has been segmented into portable and stationary.
• On the basis of the indication, the market has been divided into sepsis, renal diseases and others.
• Based on the end user, the market has been categorized into hospitals and clinics, dialysis centers, and others.
• On the geographical front, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
• The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Aethlon Medical Inc., Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, CytoSorbents Corporation, Fresenius SE & Co. KGaA, Healthwell Medical Tech. Co. Ltd., Jafron Biomedical Co. Ltd., Kaneka Corporation, Medtronic plc, Nikkiso Co ltd., and Spectral Medical Inc.
   

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800